Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality

European Journal of Neurology

Volumn 22, Issue 12, 2015, Pages 1564-1572

  Danti, S ^a   Toschi, N ^b,c,d   Diciotti, S ^e   Tessa, C ^a   Poletti, M ^f   Del Dotto, P ^a   Lucetti, C ^a  

^a Versilia Hospital   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f PATHOLOGY UNIT   (Italy)

Author keywords

Clinical phenotypes; Cortical thickness and cortical folding; Mild cognitive impairment; Motor laterality; MR imaging; Parkinson's disease

Indexed keywords

ADULT; ARTICLE; BODY POSITION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRONTAL CORTEX; FRONTOPARIETAL CORTEX; GAIT DISORDER; HAND TREMOR; HEMISPHERIC DOMINANCE; HIPPOCAMPUS; HUMAN; IMAGING SOFTWARE; INSULA; MALE; MILD COGNITIVE IMPAIRMENT; MOTOR DYSFUNCTION; MOTOR LATERALITY; NERVOUS SYSTEM PARAMETERS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SYMPTOM; TEMPORAL CORTEX; THALAMUS; AGED; BRAIN CORTEX; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

AGED; CEREBRAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; PHENOTYPE; THALAMUS;

EID: 84947017646     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12785     Document Type: Article

References (33)

1. Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010; 75: 1062-1069.
2. Poletti M, Frosini D, Pagni P, et al. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83: 601-606.
3. Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011; 68: 1562-1568.
4. Hanganu A, Bedetti C, Jubault T, et al. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration. Mov Disord 2013; 28: 1360-1369.
5. Tessa C, Lucetti C, Giannelli M, et al. Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. Hum Brain Mapp 2014; 35: 3932-3944.
6. Jubault T, Gagnon JF, Karama S, et al. Patterns of cortical thickness and surface area in early Parkinson's disease. NeuroImage 2011; 55: 462-467.
7. Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, et al. Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease. PLoS One 2013; 8: e54980.
8. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 2012; 33: 2521-2534.
9. Kim JS, Yang JJ, Lee JM, Youn J, Kim JM, Cho JW. Topographic pattern of cortical thinning with consideration of motor laterality in Parkinson disease. Parkinsonism Relat Disord 2014; 20: 1186-1190.
10. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990; 40: 1529-1534.
11. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012; 27: 349-356.
12. Fischl B. FreeSurfer. NeuroImage 2012; 62: 774-781.
13. Schaer M, Cuadra MB, Tamarit L, Lazeyras F, Eliez S, Thiran JP. A surface-based approach to quantify local cortical gyrification. IEEE Trans Med Imaging 2008; 27: 161-170.
14. Greve DN, Van der Haegen L, Cai Q, et al. A surface-based analysis of language lateralization and cortical asymmetry. J Cogn Neurosci 2013; 25: 1477-1492.
15. Biundo R, Calabrese M, Weis L, et al. Anatomical correlates of cognitive functions in early Parkinson's disease patients. PLoS One 2013; 8: e64222.
16. Pellicano C, Assogna F, Piras F, Caltagirone C, Pontieri FE, Spalletta G. Regional cortical thickness and cognitive functions in non-demented Parkinson's disease patients: a pilot study. Eur J Neurol 2012; 19: 172-175.
17. Hanganu A, Bedetti C, Degroot C, et al. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Brain 2014; 137: 1120-1129.
18. Compta Y, Pereira JB, Rios J, et al. Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. Parkinsonism Relat Disord 2013; 19: 717-724.
19. Ibarretxe-Bilbao N, Junque C, Segura B, et al. Progression of cortical thinning in early Parkinson's disease. Mov Disord 2012; 27: 1746-1753.
20. Tinaz S, Courtney MG, Stern CE. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011; 26: 436-441.
21. Zarei M, Ibarretxe-Bilbao N, Compta Y, et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013; 84: 875-881.
22. Pereira JB, Svenningsson P, Weintraub D, et al. Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology 2014; 82: 2017-2025.
23. Nishio Y, Hirayama K, Takeda A, et al. Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010; 17: 1090-1097.
24. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 2011; 26: 289-296.
25. Segura B, Baggio HC, Marti MJ, et al. Cortical thinning associated with mild cognitive impairment in Parkinson's disease. Mov Disord 2014; 29: 1495-1503.
26. Yang J. The role of the right hemisphere in metaphor comprehension: A meta-analysis of functional magnetic resonance imaging studies. Human Brain Mapping 2014; 35: 107-122.
27. Parks RW, Loewenstein DA, Dodrill KL, et al. Cerebral metabolic effects of a verbal fluency test: a PET scan study. J Clin Exp Neuropsychol 1998; 10: 565-575.
28. Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bartres-Faz D, Tolosa E. Structural brain correlates of verbal fluency in Parkinson's disease. NeuroReport 2009; 20: 741-744.
29. Sollinger AB, Goldtsein FC, Lah JJ, et al. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord 2010; 16: 177-180.
30. Uc EY, McDermott MP, Marder KS, et al. Incidence of risk factors for cognitive impairment in an early clinical Parkinson disease clinical trial cohort. Neurology 2009; 73: 1469-1477.
31. Mak E, Bergsland N, Dwyer MG, Zivadinov R, Kandiah N. Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis. Am J Neuroradiol 2014; 35: 2257-2264.
32. Melamed E, Poewe W. Taking sides: is handedness involved in motor asymmetry of Parkinson's disease? Mov Disord 2012; 27: 171-173.
33. Cachia A, Paillere-Martinot ML, Galinowski A, et al. Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations. NeuroImage 2008; 39: 927-935.